Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes

Grossberg AJ, Chu LC, Deig CR, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020;70:375–403.

Article  PubMed  PubMed Central  Google Scholar 

Riquelme E, Zhang Y, Zhang L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795-806.e12.

Article  PubMed  PubMed Central  CAS  Google Scholar 

de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374–403.

Article  PubMed  Google Scholar 

Pfeifer E, Burchell JM, Dazzi F, et al. Apoptosis in the pancreatic cancer tumor microenvironment-the double-edged sword of cancer-associated fibroblasts. Cells. 2021;10:1653–70.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hessmann E, Buchholz SM, Demir IE, et al. Microenvironmental determinants of pancreatic cancer. Physiol Rev. 2020;100:1707–51.

Article  PubMed  Google Scholar 

Seton-Rogers S. Fibroblasts shape PDAC architecture. Nat Rev Cancer. 2019;19:418.

Article  PubMed  CAS  Google Scholar 

Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer. 2022;22:131–42.

Article  PubMed  CAS  Google Scholar 

Atkinson MA, Campbell-Thompson M, Kusmartseva I, et al. Organisation of the human pancreas in health and in diabetes. Diabetologia. 2020;63:1966–73.

Article  PubMed  PubMed Central  Google Scholar 

Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008;134:981–7.

Article  PubMed  CAS  Google Scholar 

Aggarwal G, Kamada P, Chari ST. Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas. 2013;42:198–201.

Article  PubMed  PubMed Central  Google Scholar 

2. Diagnosis and Classification of Diabetes. Standards of Care in Diabetes-2024. Diabetes Care. 2024;47:S20-42.

Article  Google Scholar 

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care. 2003;26(Suppl 1):S5-20.

Article  Google Scholar 

Ewald N, Kaufmann C, Raspe A, et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338–42.

Article  PubMed  CAS  Google Scholar 

Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(3573–87): e29.

Google Scholar 

Do VH, Canzar S. A generalization of t-SNE and UMAP to single-cell multimodal omics. Genome Biol. 2021;22:130–8.

Article  PubMed  PubMed Central  Google Scholar 

Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12:1088–107.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wigger L, Barovic M, Brunner AD, et al. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes. Nat Metab. 2021;3:1017–31.

Article  PubMed  CAS  Google Scholar 

Kamarajah SK, Burns WR, Frankel TL, et al. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging system for patients with pancreatic adenocarcinoma: a surveillance, epidemiology and end results (SEER) analysis. Ann Surg Oncol. 2017;24:2023–30.

Article  PubMed  Google Scholar 

Kasurinen J, Hagström J, Kaprio T, et al. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: the additional prognostic value of CD8+-to-CD3+ ratio remains debatable. Tumour Biol. 2022;44:37–52.

Article  PubMed  Google Scholar 

Ackermann Misfeldt A, Costa RH, Gannon M. Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1. Diabetes. 2008;57:3069–77.

Article  PubMed  PubMed Central  Google Scholar 

Kao KC, Vilbois S, Tsai CH, et al. Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol. 2022;24:1574–83.

Article  PubMed  CAS  Google Scholar 

Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–37.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348:74–80.

Article  PubMed  CAS  Google Scholar 

Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309–22.

Article  PubMed  CAS  Google Scholar 

Rebelo R, Xavier CPR, Giovannetti E, et al. Fibroblasts in pancreatic cancer: molecular and clinical perspectives. Trends Mol Med. 2023;29:439–53.

Article  PubMed  CAS  Google Scholar 

Caronni N, la Terza F, Vittoria FM, et al. IL-1β (+) macrophages fuel pathogenic inflammation in pancreatic cancer. Nature. 2023;623:415–22.

Article  PubMed  CAS  Google Scholar 

Wang Y, Ni Q, Sun J, et al. Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer. J Clin Endocrinol Metab. 2020;105:dgz224.

Article  PubMed  Google Scholar 

Javeed N, Sagar G, Dutta SK, et al. Pancreatic cancer-derived exosomes cause paraneoplastic β-cell dysfunction. Clin Cancer Res. 2015;21:1722–33.

Article  PubMed  CAS  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.

Article  PubMed  Google Scholar 

Liao WC, Tu YK, Wu MS, et al. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ. 2015;350:g7371–82.

Article  PubMed  PubMed Central  Google Scholar 

Quoc Lam B, Shrivastava SK, Shrivastava A, et al. The Impact of obesity and diabetes mellitus on pancreatic cancer: molecular mechanisms and clinical perspectives. J Cell Mol Med. 2020;24:7706–16.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pizzato M, Turati F, Rosato V, et al. Exploring the link between diabetes and pancreatic cancer. Expert Rev Anticancer Ther. 2019;19:681–7.

Article  PubMed  CAS  Google Scholar 

Hart PA, Bellin MD, Andersen DK, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroent

Comments (0)

No login
gif